All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
Status | Trial ID | Title | Completion date | Category |
---|---|---|---|---|
Ongoing | 2006-000228-14 | Immunization of disease-free melanoma patients with different HLA-A2 peptides. | not-yet-due | |
Ongoing | 2006-000353-21 | Comparison of the vasoreactivity and endogenous NO production between the left and right internal mammary 6 months after bypass surgery with the injection of substance P and exogenous nitric oxide. | not-yet-due | |
Ongoing, reported early | 2006-001780-30 | A PHASE II STUDY OF SU011248 IN PATIENTS WITH RECURRENT AND/OR METASTATIC SQUAMOUS HEAD AND NECK CARCINOMA. | not-yet-due | |
Other | 2006-003549-18 | Reduction of Bone Morbidity Using an Oral Bisphosphonate in Fibrous Dysplasia of Bone | not-yet-due | |
Ongoing | 2006-004635-30 | A randomized multicentric phase II study of prolonged adjuvant Temozolomide or "stop and go" in glioblastoma patients : the PATSGO study. | not-yet-due | |
Ongoing | 2006-004830-34 | TACROLIMUS AND PRETRANSPLANT HIGH-DOSE R-ATG INDUCTION VS TACROLIMUS MONOTHERAPY AS TOLEROGENIC IMMUNOSUPPRESSION IN ADULT LIVER TRANSPLANTATION.AN OPEN LABEL, RANDOMISED, PROSPECTIVE AND CONTROLLED T... | not-yet-due | |
Ongoing | 2006-005386-19 | Cytokines and inflammatory proteins gene expression study in synovial biopsies from rheumatoid arthritis patients refractory to anti-TNF therapy treated with Rituximab | not-yet-due | |
Ongoing | 2007-001559-20 | Steady-state pharmacokinetics of high dose acetaminophen inpost-op children. Rational use of N-acetyl cysteine for prevention of liver toxicity related to cumulative doses. | not-yet-due | |
Ongoing | 2007-002940-86 | Sepsis, Endothelial function, and Lipids in critically ill patients with Liver Failure (SELLIFA). Nutritional sub-study : Randomized controlled trial comparing the tolerance on lipid metabolism and sa... | not-yet-due | |
Completed, but no date | 2007-003023-20 | TACROLIMUS – DACLIZUMAB - MYCOPHENOLATE MOFETIL IMMUNE PROPHYLAXIS IN PEDIATRIC LIVER TRANSPLANTATION. An open, pilot, investigator-driven study in 20 recipients | bad-data | |
Ongoing | 2007-003223-20 | Temocillin use in intensive care units: A Pharmacokinetic study of 6g per day in conventional administration vs. continuous infusion | not-yet-due | |
Ongoing | 2007-004694-26 | A Comparative Study Of A 6-Month Infliximab (Remicade) Or Placebo Regimen In Undifferentiated Arthritis At High Risk For The Development Of Rheumatoid Arthritis : Clinical, Radiological (MRI) And Syno... | not-yet-due | |
Ongoing | 2007-004911-79 | Pharmacodynamics of Fondaparinux subcutaneous versus continuous intravenous infusion in critically ill patients with or without vasopressors. | not-yet-due | |
Exempt | 2008-001354-41 | Neoadjuvant cetuximab monotherapy followed by surgery in squamous cell carcinoma of head and neck: phase I/II study | not-yet-due | |
Ongoing | 2008-003167-39 | Effet du fluconazole sur le taux d'anticorps anti-Saccharomyces cerevisiae (ASCSA) après résection chirurgicale pour maladie de Crohn. | not-yet-due | |
Ongoing | 2008-004575-21 | A single arm, multicenter, phase II trial of RAD001 as monotherapy in the palliative treatment of patient with locally advanced or metastatic transitional cell carcinoma after failure of platinum-base... | not-yet-due | |
Ongoing, reported early | 2008-004707-59 | A phase II study of CP-751,871 in patients with recurrent and/or metastatic squamous head and neck carcinoma | not-yet-due | |
Completed, but no date | 2008-008720-33 | A one year, open, prospective study on the role of quarterly intravitreal injections of Lucentis 0,5 mg (ranibizumab) in preventing of delaying progression of radiation retinopathy in eyes treated wit... | bad-data | |
Not reported | 2009-010759-29 | étude clinique sur l’administration de 3 doses de betaméthasone (12mg) à 18 heures d’intervalle lors d’une menace d’accouchement prématuré dans les grossesses gémellaires traitées par Atosiban, plutôt... | 2016-07-26 | due-trials |
Completed, but no date Terminated | 2009-011325-14 | Phase II Study of Preoperative Panitumumab and External Beam Radiotherapy in Patients with Locally Advanced Rectal Cancer | bad-data | |
Not reported | 2009-015237-76 | An open label multicentric phase II study of Panitumumab (Vectibix®) in cutaneous squamous cell carcinoma (SCC) | 2017-01-17 | due-trials |
Exempt | 2010-018638-29 | Phase I/II study of peptide vaccination associated with GM-CT-01, a galactomannan oligomer that inhibits galestin-3, in patients with advanced metastatic melanoma | not-yet-due | |
Not reported | 2010-019873-13 | Comparative study of the clinical response and cardiorespiratory endurance in early rheumatoid arthritis patients treated with Tociluzimab or Methotrexate Addendum protocol : Global gene expression pr... | 2013-09-16 | due-trials |
Completed, but no date Terminated | 2010-019983-35 | Phase I-II study of low dose CdA combined with valproic acid (VPA) in previously treated B-cell chronic lymphocytic leukemia (CLL) patients. | bad-data | |
Ongoing | 2011-001756-12 | Surrogate markers evaluation in pre-demented Alzheimer’s disease patients and healthy elderly controls | not-yet-due | |
Completed, but no date | 2011-001938-42 | Randomized Phase II Study of CABAZITAXEL versus METHOTREXATE in patients with recurrent or metastatic squamous cell carcinoma of the head and neck previously treated with platinum-based therapy | bad-data | |
Ongoing | 2011-003124-12 | A prospective phase II study on dose escalation using PET based adaptive IMRT stage II-III non small lung cancer | not-yet-due | |
Ongoing | 2011-005174-27 | Phase II study of High-Dose Rituximab in High Risk Chronic Lymphocytic Leukemia in Suboptimal Response after Induction Immunochemotherapy | not-yet-due | |
Completed, report not yet due | 2011-005274-30 | Efficacy and safety of a Double Icodextrin Dose in elderly incident CAPD patients on incremental Peritoneal Dialysis therapy: the DIDo study | 2020-02-28 | not-yet-due |
Completed, report not yet due | 2011-006085-40 | A proof of concept study to evaluate the use of metabonomics and lipidomics in predicting toxicity and efficacy of anti-VEGF therapy in patients with metastatic clear cell renal cell carcinoma. | 2020-10-15 | not-yet-due |
Ongoing | 2012-003314-13 | RING – RItuximab for lupus Nephritis with remission | not-yet-due | |
Ongoing, reported early | 2012-003774-76 | Perioperative ketorolac in high risk breast cancer patients with and without inflammation. A prospective randomized placebo-controlled trial. | not-yet-due | |
Completed, but no date Terminated | 2012-004123-20 | A single arm, multicenter, phase II study of BEZ235 as monotherapy in | bad-data | |
Ongoing | 2012-005076-34 | Prolonged-release oral Fampridine in Multiple Sclerosis: effects on clinical, neurophysiological and quantified gait analysis parameters. A cross-over, double-blinded, placebo-controlled study. | not-yet-due | |
Completed, but no date Terminated | 2012-005249-19 | Randomized Phase 2 study comparing pathological responses observed on colorectal cancer metastases resected after preoperative treatment combining cetuximab with FOLFOX or FOLFIRI in RAS and B-RAF WT ... | bad-data | |
Ongoing | 2012-005376-34 | Randomized Phase 2 study comparing pathological responses observed on colorectal cancer metastases resected after preoperative treatment combining bevacizumab with FOLFOX or FOLFIRI. | not-yet-due | |
Ongoing | 2013-000615-24 | Tacrolimus disposition in pediatric transplantation: influence of age, | not-yet-due | |
Completed, but no date Terminated | 2014-003856-30 | Sandostatin (Octreotide LAR) may lead to clinical improvement through receptor occupation optimisation. A prospective interventional trial of patients with neuro-endocrine tumors with carcinoid syndro... | bad-data | |
Ongoing | 2014-004224-22 | Temocillin pharmacokinetics in paediatrics | not-yet-due | |
Completed, but no date | 2014-005170-11 | Can we get conscious sedation in optimal safety conditions in an emergency department, by combining dexmedetomidine with alfentanil? | bad-data | |
Ongoing | 2015-001246-28 | Ultrasound scores as imaging biomarkers of early response to subcutaneous tocilizumab in association with methotrexate in early rheumatoid arthritis (TOVERA study) | not-yet-due | |
Ongoing | 2015-001703-32 | Phase III multicentric study evaluating the efficacy and safety of sirolimus in Vascular Anomalies that are refractory to standard care | not-yet-due | |
Ongoing | 2015-003146-75 | A multi-centre randomized, placebo-controlled trial of mirabegron, a new beta3-adrenergic receptor agonist on the progression of left ventricular mass and diastolic function in patients with structura... | not-yet-due | |
Not reported | 2016-005062-61 | Effects of vitamin D supplementation during a non-surgical treatment of generalized chronic periodontitis: a randomized double-blinded placebo-controlled clinical trial | 2018-09-22 | due-trials |
Completed, but no date Terminated | 2017-001619-35 | Exploratory pathophysiological study in five patients suffering from new-onset lupus nephritis and treated with rituximab as first-line treatment | bad-data | |
Ongoing | 2017-002007-97 | Does LOW Dose DEXmedetomidine After Cardiopulmonary Bypass Separation | not-yet-due | |
Ongoing | 2017-002473-19 | PREDICTIVE FACTORS AND MAGNITUDE OF RESPONSE TO OMALIZUMAB AND MEPOLIZUMAB IN ALLERGIC AND EOSINOPHILIC SEVERE ASTHMA: | not-yet-due | |
Ongoing | 2017-002532-16 | Adjunctive systemic antimicrobial therapy in the surgical treatment of peri-implantitis. A prospective randomized clinical study | not-yet-due | |
Completed, but no date, and reported results | 2017-003406-40 | Repetitive blood donations and endurance sport performance: does iron supplementation limit the negative effects on hematological parameters? | bad-data | |
Ongoing | 2017-004493-34 | Evaluation of multiple subgingival irrigations with 10% povidone iodine after scaling and root planing : a randomized clinical trial | not-yet-due | |
Ongoing | 2018-001096-20 | Avelumab combined with cetuximab and irinotecan for treatment refractory metastatic colorectal microsatellite stable cancer – A proof of concept, open label non-randomized Phase IIa study. | not-yet-due | |
Ongoing | 2018-002499-42 | Evaluation of the effect of repeated injections of high doses of botulinum toxin into the lower limb of spastic brain lesions on functional and biomechanical parameters of walking | not-yet-due | |
Ongoing | 2018-004191-35 | Evaluation of the safety and efficacy of administration of Empagliflozin in a new treatment for neutropenia in patients with Glycogen Storage Disease type 1b (GSD1b) and G6PC3 deficiency. | not-yet-due | |
Ongoing | 2019-000572-41 | An open label phase II study combining Nivolumab and Celecoxib | not-yet-due | |
Ongoing | 2019-001204-37 | A randomized, double-blind, placebo-controlled, cross-over, multi-center trial in healthy subjects to investigate the effects of lacosamide, pregabalin and tapentadol on biomarkers of pain processing ... | not-yet-due | |
No trial status on register | 2019-003573-26 | Monocentric pilot trial evaluating efficacy of Trametinib in Arteriovenous Malformations that are refractory to standard treatments or for which standard treatment are contra-indicated | bad-data |